Arrowpoint Investment Partners »

Repligen Corporation shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Repligen Corporation (RGEN) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Repligen Corporation

Tip: Access up to 7 years of quarterly data

All positions including Repligen Corporation held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repligen Corporation by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $203k 1.5k 133.67

More positions owned by Arrowpoint Investment Partners

Aegon Amer Reg 1 Cert (AEG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Hallador Energy (HNRG)
Echostar Corp Cl A (SATS)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Astera Labs (ALAB)
Atour Lifestyle Hldgs Sponsored Ads (ATAT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Bristol Myers Squibb Call Option (BMY)
Merck & Co Call Option (MRK)
Pfizer Call Option (PFE)
Abbvie Call Option (ABBV)
Hesai Group Sponsored Ads (HSAI)
Comfort Systems USA (FIX)

View all positions for Arrowpoint Investment Partners

Top funds holding Repligen Corporation

BlackRock
Vanguard Group
United Capital Financial Advisers
FMR
State Street Corporation
Citadel Advisors
Point72 Asset Management
Holocene Advisors
Champlain Investment Partners
Bank of New York Mellon
Alliancebernstein
Geode Capital Management
Conestoga Capital Advisors
Millennium Management
Invesco

View all funds holding Repligen Corporation